Richard Roths Media Announces $52 Million Dollar Investment Approval to Expand its AI-Driven Marketing Systems 
Four Inc. Secures Spot on Washington Technology’s Top 100 Government Contractors List for 11th Consecutive Year 
Tat Hong Equipment Service Co., Ltd. Announces 2025/26 Annual Results Sutro Biopharma Reports First Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
– Data from the Phase 1 dose-expansion study for luveltamab tazevibulin, or luvelta, for patients…
ContraFect Reports First Quarter 2023 Financial Results and Provides Business Update
YONKERS, N.Y., May 15, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology…
Nuvectis Pharma Announces FDA Clearance of NXP900 IND
Fort Lee, NJ, May 15, 2023 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis”…
Benitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational Update
9 subjects enrolled into the OPMD clinical development program HAYWARD, Calif., May 15, 2023 (GLOBE…
Vir Biotechnology Appoints Jeff Calcagno, M.D., as Executive Vice President and Chief Business Officer
SAN FRANCISCO, May 15, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
Cue Biopharma to Present at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Company to host Investor Update call on June 14, 2023 to review and discuss the…
Cocrystal Pharma Reports First Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
BOTHELL, Wash., May 15, 2023 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the…
InspireMD Announces Private Placement of Up to $113.6 Million
Led by Marshall Wace with participation from OrbiMed, Rosalind, Nantahala, Soleus, Velan and certain InspireMD Board members…
Shockwave Medical Launches New Coronary IVL Catheter Internationally and Enrolls First Patient in All-Female Empower Study
Shockwave C2+ Catheter Expands Utility of IVL in Calcified Coronary Arteries SANTA CLARA, Calif., May…
Locanabio Announces Equity Investment from CureDuchenne Ventures to Support Development of snRNA Exon Skipping Approach for Duchenne Muscular Dystrophy (DMD)
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) — Locanabio, Inc., a genetic medicines company developing…
Ocuphire Pharma Announces Financial Results for First Quarter 2023 and Provides Corporate Update
End-of-Phase 2 Meeting with FDA Anticipated in 2H 2023 to Confirm Phase 3 Regulatory Path…
Alimera Sciences Reports First Quarter 2023 Results
Consolidated Net Revenue of $13.5 Million Up 14% vs. First Quarter of 2022 Global End…
Ikena Oncology Reports First Quarter 2023 Financial Results and Highlights Advancements Across Targeted Oncology Pipeline
Lead targeted oncology program in Hippo pathway, IK-930, continues to advance through dose escalation with…
Decibel Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update
– Initiated CHORD™, a global Phase 1/2 dose escalation clinical trial of lead gene therapy…
Ikena Oncology Announces $40 Million Underwritten Offering
BOSTON, May 15, 2023 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”, “Company”), a targeted…
Bavarian Nordic Completes Acquisition of Travel Vaccine Portfolio from Emergent BioSolutions
COPENHAGEN, Denmark, May 15, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today that it…
POINT Biopharma Makes Strategic Investment in Commercial-Scale Alpha-Emitting Isotope Manufacturer
POINT further strengthens supply chain with $10 million investment in Ionetix Alpha Corp. INDIANAPOLIS and…
PDS Biotech Provides Business Update and Reports First Quarter 2023 Financial Results
Updated data from VERSATILE-002 Phase 2 trial to be presented at ASCO 2023 Company to…
BridgeBio Pharma to Present Updated Data from its BBP-812 Canavan Disease Gene Therapy Program at the 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
PALO ALTO, Calif., May 15, 2023 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”…
POINT Biopharma Reports First Quarter 2023 Financial Results and Provides Business Highlights
U.S. FDA granted Fast Track designation for 177Lu-PNT2002 for the treatment of mCRPC in April…